Table 1.
All (n = 403) | MSS (n = 351) | MSI (n = 52) | p Value a | |
---|---|---|---|---|
Age (years) b | 0.55 | |||
≤68 years | 221 | 190 | 31 | |
>68 years | 182 | 161 | 21 | |
Gender | 0.34 | |||
Male | 207 | 184 | 23 | |
Female | 196 | 167 | 29 | |
Tumor Site c | 0.005 | |||
Right Colon | 145 | 115 | 30 | |
Left Colon | 145 | 134 | 11 | |
Rectum | 113 | 102 | 11 | |
Serum CEA Levels | 0.98 | |||
≤3.5 ng/mL | 237 | 207 | 30 | |
>3.5 ng/mL | 166 | 144 | 22 | |
Performance Status | 0.69 | |||
0 | 120 | 102 | 18 | |
1 | 203 | 178 | 25 | |
2 | 80 | 71 | 9 | |
NPS d | 0.79 | |||
0 | 76 | 67 | 9 | |
1 | 211 | 185 | 26 | |
2 | 116 | 99 | 17 | |
Tumor Size b | 0.87 | |||
≤4 cm | 240 | 208 | 32 | |
>4 cm | 163 | 143 | 20 | |
pT Stage | 0.48 | |||
0 | 9 | 8 | 1 | |
1 | 22 | 20 | 2 | |
2 | 82 | 73 | 9 | |
3 | 217 | 187 | 30 | |
4a | 65 | 56 | 9 | |
4b | 8 | 7 | 1 | |
1–2 | 113 | 101 | 12 | 0.49 |
3–4 | 290 | 250 | 40 | |
pN Stage | 0.62 | |||
0 | 245 | 215 | 30 | |
1a | 46 | 40 | 6 | |
1b | 48 | 42 | 6 | |
1c | 13 | 11 | 2 | |
2a | 15 | 12 | 3 | |
2b | 27 | 22 | 5 | |
Nx | 9 | 9 | 0 | |
Node Negative | 245 | 215 | 30 | 0.73 |
Node Positive | 149 | 127 | 22 | |
pM Stage | 0.08 | |||
0 | 314 | 278 | 36 | |
1a | 66 | 55 | 11 | |
1b | 10 | 8 | 2 | |
1c | 13 | 10 | 3 | |
M− | 314 | 278 | 36 | 0.15 |
M+ | 89 | 73 | 16 | |
TNM Stage | 0.44 | |||
0–II | 225 | 199 | 26 | |
III–IV | 178 | 152 | 26 | |
Dukes’s Stage | 0.21 | |||
A | 99 | 88 | 11 | |
B | 126 | 111 | 15 | |
C | 89 | 79 | 10 | |
D | 89 | 73 | 16 | |
Histologic Differentiation | 0.26 | |||
well | 8 | 8 | 0 | |
moderate | 353 | 309 | 44 | |
poor | 42 | 34 | 8 | |
Radical Resection | 0.47 | |||
Yes | 339 | 293 | 46 | |
No | 64 | 58 | 6 | |
PostOperative Complications | 0.31 | |||
No | 361 | 317 | 44 | |
Yes | 42 | 34 | 8 | |
Postoperative Chemotherapy | 0.99 | |||
No | 190 | 166 | 24 | |
Yes | 213 | 185 | 28 | |
Tumor Recurrence e | 0.70 | |||
No | 284 | 249 | 35 | |
Yes | 119 | 102 | 17 | |
Survival | 0.24 | |||
Yes | 280 | 248 | 32 | |
No | 123 | 103 | 20 |
p value refers to MSS vs. MSI tumors; CEA indicates carcinoembryonic antigen (3.5 ng/mL normal value in healthy subjects); Postoperative complications were defined as grade II or higher of the Clavien-Dindo classification [27]. a chi-square test. b median value in all series. c right colon means cecum, the ascendent colon, and the right transverse colon; the left colon means left. transverse colon, descendent colon, and sigma. d Naples Prognostic Score (reference n° 21). e including 64 non-radical operations.